Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 20.12.2014

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
20.12.14Chen Long Charges to BWF Destination Dubai World Superseries Men's Singles Final46DUBAI, UAE, December 20, 2014 /PRNewswire/ -- China's World champion and tournament top seed Chen Long survived a scare against India's Kidambi Srikanth tonight on his way to the Men's Finals of...
► Artikel lesen
20.12.14England's Adcocks Felled By Illness In Semis Of BWF Destination Dubai World Superseries Finals97DUBAI, UAE, December 20, 2014 /PRNewswire/ -- After forcing their way into the Mixed Doubles semi-finals of the BWF Destination Dubai World Superseries Finals with a hard fought win over Germany's...
► Artikel lesen
20.12.14IZON And Stream TV Team Up For Glasses-Free 3D Product Launch30PHILADELPHIA, Dec. 20, 2014 /PRNewswire/ -- Stream TV Networks, Inc.' is pleased to announce that U.S. television maker IZON, LLC has committed to a 2015 release of Ultra-D enabled products in collaboration...
► Artikel lesen
20.12.14Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze (asparaginase Erwinia chrysanthemi)76-- Expanded U.S. Labeling Offers an Alternative Method to Administer Erwinaze to Patients with ALL DUBLIN, Dec. 20, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced...
► Artikel lesen
20.12.14AIMCo Announces Designation of Mac Van Wielingen as Chair of the Board of Directors27EDMONTON, Alberta, December 19, 2014 /PRNewswire/ -- Alberta Investment Management Corporation (AIMCo) is pleased to announce the designation of Mac Van Wielingen as Chair of the Board of Directors....
► Artikel lesen
20.12.14AbbVie Receives U.S. FDA Approval of VIEKIRA PAK' (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C90- In Phase 3 clinical trials, VIEKIRA PAK cured 95-100 percent of hepatitis C patients, with less than 2 percent of patients experiencing virological failure - Tolerability profile shows...
► Artikel lesen
Suchbegriffe der letzen 24 hAnzahl
TESLA4.148
TUI4.108
NVIDIA4.092
SUPER MICRO COMPUTER3.346
BAYER3.072
VARTA2.883
NEL2.775
RHEINMETALL2.621
DEUTSCHE BANK2.010
RENK GROUP1.976
AIXTRON SE1.736
SAP1.660
DEUTSCHE LUFTHANSA1.636
EVOTEC1.583
BASF1.513
BYD1.504
PLUG POWER1.355
ALLIANZ1.302
COMMERZBANK1.249
INFINEON1.215
RWE1.178
MERCEDES-BENZ1.072
VOLKSWAGEN1.036
THYSSENKRUPP1.035
NORDEX1.016